Rang	Name	Position
1	Mr. Andrew P. Hider	CEO, Pres., Interim Group Pres. of Medical Products & Therapies and Director
2	Mr. David S. Rosenbloom	Executive VP & General Counsel
3	Ms. Maria Soriano	Group President of Infusion Therapies & Platforms
4	Mr. John Terence Rogers	Executive VP & CFO
5	Mr. Bernie Heine	Interim Chief Accounting Officer & Controller
6	Mr. Charles Patel	Senior VP & Chief Information Officer
7	Mr. Kevin Moran	Vice President & Head of Investor Relations
8	Ms. Stacey Eisen	SVP, Chief Communications Officer & Corporate Marketing and President of Baxter Foundation
9	Ms. Cynthia Carlisle	Executive VP & Chief Human Resources Officer
10	Mr. James W. Borzi	Executive VP & Chief Supply Chain Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	15,83%	2,08 Mrd. USD
2	Pzena Investment Management, LLC	12,63%	1,66 Mrd. USD
3	Dodge & Cox	11,29%	1,49 Mrd. USD
4	FMR Inc	10,43%	1,37 Mrd. USD
5	Vanguard Capital Management, LLC	6,53%	0,86 Mrd. USD
6	Vanguard Portfolio Management, LLC	4,65%	0,61 Mrd. USD
7	State Street Corp	3,98%	0,52 Mrd. USD
8	Greenhaven Associates Inc	2,76%	0,36 Mrd. USD
9	Geode Capital Management, LLC	2,73%	0,36 Mrd. USD
10	Amvescap Plc.	2,39%	0,32 Mrd. USD
11	UBS Group AG	1,84%	0,24 Mrd. USD
12	First Pacific Advisors, LP	1,47%	0,19 Mrd. USD
13	The Goldman Sachs Group Inc	1,38%	0,18 Mrd. USD
14	Equity Investment Corp	1,33%	0,18 Mrd. USD
15	Morgan Stanley - Brokerage Accounts	1,23%	0,16 Mrd. USD
16	Bank of America Corp	1,21%	0,16 Mrd. USD
17	State Farm Mutual Automobile Ins Co	1,20%	0,16 Mrd. USD
18	Charles Schwab Investment Management Inc	1,16%	0,15 Mrd. USD
19	Dimensional Fund Advisors, Inc.	1,09%	0,14 Mrd. USD
20	Northern Trust Corp	0,94%	0,12 Mrd. USD